Drugs are still being approved and reports are still churning out, all while the FDA battles the COVID-19 outbreak.
The federal health agencies have taken steps to provide better telemedicine services during the outbreak.
Chloroquine is being investigated as a potential treatment for patients with mild to moderate COVID-19, to reduce the duration of symptoms as well as viral shedding.
A separate trial is evaluating a treatment for patients already sick with COVID-19.
The federal government is stripping away barriers to Medicare telehealth coverage as a frontline response to the coronavirus outbreak, which feeds on person-to-person contact and has proven deadliest for elderly individuals.
The Food and Drug Administration has announced that it will not object to the New York State Department of Health authorizing certain laboratories in New York to start testing patients for coronavirus disease 2019 once the tests have been validated.
Unapproved products are being marketed as coronavirus 2019 cures
The FDA said its focus going forward was education, research and enforcement.
President Trump wanted to know how quickly pharma could have a vaccine or treatment ready for public use.
Please login or register first to view this content.